{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:49:24Z","timestamp":1793900964451,"version":"4.8.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"PUPT"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12882-017-0736-x","type":"journal-article","created":{"date-parts":[[2017,10,31]],"date-time":"2017-10-31T11:48:12Z","timestamp":1509450492000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":91,"title":["Uric acid causes kidney injury through inducing fibroblast expansion, Endothelin-1 expression, and inflammation"],"prefix":"10.1186","volume":"18","author":[{"given":"Muhammad Mansyur","family":"Romi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nur","family":"Arfian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Untung","family":"Tranggono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiwit Ananda Wahyu","family":"Setyaningsih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dwi Cahyani Ratna","family":"Sari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,31]]},"reference":[{"issue":"Suppl 3","key":"736_CR1","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1365-2362.2006.01689.x","volume":"36","author":"W Neuhofer","year":"2006","unstructured":"Neuhofer W, Pittrow D. Role of endothelin and endothelin receptor antagonists in renal disease. Eur J Clin Investig. 2006;36(Suppl 3):78\u201388.","journal-title":"Eur J Clin Investig"},{"issue":"12","key":"736_CR2","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1097\/01.ASN.0000034910.58454.FD","volume":"13","author":"DH Kang","year":"2002","unstructured":"Kang DH, Nakagawa T, et al. A role for uric acid in the progression of renal disease. J Am Soc Nephrol. 2002;13(12):2888\u201397.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"736_CR3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.semnephrol.2004.09.007","volume":"25","author":"J Kanellis","year":"2005","unstructured":"Kanellis J, Kang DH. Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. Semin Nephrol. 2005;25(1):39\u201342.","journal-title":"Semin Nephrol"},{"issue":"1","key":"736_CR4","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/BF00163854","volume":"34","author":"XW Wu","year":"1992","unstructured":"Wu XW, Muzny DM, et al. Two independent mutational events in the loss of urate oxidase during hominoid evolution. J Mol Evol. 1992;34(1):78\u201384.","journal-title":"J Mol Evol"},{"issue":"6","key":"736_CR5","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1161\/01.HYP.0000069700.62727.C5","volume":"41","author":"RJ Johnson","year":"2003","unstructured":"Johnson RJ, Kang DH, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension. 2003;41(6):1183\u201390.","journal-title":"Hypertension"},{"issue":"6887","key":"736_CR6","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nature742","volume":"417","author":"A Enomoto","year":"2002","unstructured":"Enomoto A, Kimura H, et al. Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature. 2002;417(6887):447\u201352.","journal-title":"Nature"},{"issue":"5","key":"736_CR7","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1681\/ASN.2005090949","volume":"17","author":"C Zoccali","year":"2006","unstructured":"Zoccali C, Maio R, et al. Uric acid and endothelial dysfunction in essential hypertension. J Am Soc Nephrol. 2006;17(5):1466\u201371.","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"736_CR8","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1681\/ASN.2008010080","volume":"19","author":"RP Obermay","year":"2008","unstructured":"Obermay RP, Temml C, et al. Elevated uric acid increases the risk for kidney disease. J Am Soc Nephrol. 2008;19(12):2407\u201313.","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"736_CR9","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1097\/HJH.0b013e32830e4945","volume":"26","author":"P Mene","year":"2008","unstructured":"Mene P, Punzo G. Uric acid: bystander or culprit in hypertension and progressive renal disease? J Hypertens. 2008;26(11):2085\u201392.","journal-title":"J Hypertens"},{"issue":"5","key":"736_CR10","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/0002-9343(75)90222-3","volume":"59","author":"L Berger","year":"1975","unstructured":"Berger L, Yu TF. Renal function in gout. IV. An analysis of 524 gouty subjects including long-term follow-up studies. Am J Med. 1975;59(5):605\u201313.","journal-title":"Am J Med"},{"issue":"7427","key":"736_CR11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0140-6736(66)90005-5","volume":"1","author":"A Breckenridge","year":"1966","unstructured":"Breckenridge A. Hypertension and hyperuricaemia. Lancet. 1966;1(7427):15\u20138.","journal-title":"Lancet"},{"issue":"1","key":"736_CR12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/oxfordjournals.aje.a113972","volume":"121","author":"FN Brand","year":"1985","unstructured":"Brand FN, McGee DL, et al. Hyperuricemia as a risk factor of coronary heart disease: the Framingham study. Am J Epidemiol. 1985;121(1):11\u20138.","journal-title":"Am J Epidemiol"},{"issue":"9","key":"736_CR13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1056\/NEJM196609012750902","volume":"275","author":"PJ Cannon","year":"1966","unstructured":"Cannon PJ, Stason WB, et al. Hyperuricemia in primary and renal hypertension. N Engl J Med. 1966;275(9):457\u201364.","journal-title":"N Engl J Med"},{"issue":"4","key":"736_CR14","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1172\/JCI115142","volume":"87","author":"FS di Giovine","year":"1991","unstructured":"di Giovine FS, Malawista SE, et al. Urate crystals stimulate production of tumor necrosis factor alpha from human blood monocytes and synovial cells. Cytokine mRNA and protein kinetics, and cellular distribution. J Clin Invest. 1991;87(4):1375\u201381.","journal-title":"J Clin Invest"},{"issue":"6","key":"736_CR15","doi-asserted-by":"crossref","first-page":"F991","DOI":"10.1152\/ajprenal.00283.2001","volume":"282","author":"M Mazzali","year":"2002","unstructured":"Mazzali M, Kanellis J, et al. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol. 2002;282(6):F991\u20137.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"736_CR16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1523-1755.2005.00074.x","volume":"67","author":"LG Sanchez-Lozada","year":"2005","unstructured":"Sanchez-Lozada LG, Tapia E, et al. Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats. Kidney Int. 2005;67(1):237\u201347.","journal-title":"Kidney Int"},{"issue":"13","key":"736_CR17","doi-asserted-by":"crossref","first-page":"8604","DOI":"10.1016\/S0021-9258(18)93017-6","volume":"266","author":"GN Rao","year":"1991","unstructured":"Rao GN, Corson MA, et al. Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression. J Biol Chem. 1991;266(13):8604\u20138.","journal-title":"J Biol Chem"},{"issue":"6","key":"736_CR18","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1161\/01.HYP.0000072820.07472.3B","volume":"41","author":"J Kanellis","year":"2003","unstructured":"Kanellis J, Watanabe S, et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension. 2003;41(6):1287\u201393.","journal-title":"Hypertension"},{"issue":"6163","key":"736_CR19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/332411a0","volume":"332","author":"M Yanagisawa","year":"1998","unstructured":"Yanagisawa M, Kurihara H, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1998;332(6163):411\u20135.","journal-title":"Nature"},{"issue":"2","key":"736_CR20","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1523-1755.2004.00779.x","volume":"66","author":"K Inazaki","year":"2004","unstructured":"Inazaki K, Kanamaru Y, et al. Smad3 deficiency attenuates renal fibrosis, inflammation,and apoptosis after unilateral ureteral obstruction. Kidney Int. 2004;66(2):597\u2013604.","journal-title":"Kidney Int"},{"issue":"2","key":"736_CR21","doi-asserted-by":"crossref","first-page":"F336","DOI":"10.1152\/ajprenal.00053.2010","volume":"299","author":"Z Yang","year":"2010","unstructured":"Yang Z, Xiaohua W, et al. Uric acid increases fibronectin synthesis through upregulation of lysyl oxidase expression in rat renal tubular epithelial cells. Am J Physiol Renal Physiol. 2010;299(2):F336\u201346.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"736_CR22","doi-asserted-by":"crossref","first-page":"e39738","DOI":"10.1371\/journal.pone.0039738","volume":"7","author":"Y Zhou","year":"2012","unstructured":"Zhou Y, Fang L, et al. Uric acid induces renal inflammation via activating tubular NF-\u03baB signaling pathway. PLoS One. 2012;7(6):e39738.","journal-title":"PLoS One"},{"key":"736_CR23","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00005792-196012000-00001","volume":"39","author":"JH Talbott","year":"1960","unstructured":"Talbott JH, Terplan KL. The kidney in gout. Medicine (Baltimore). 1960;39:405\u201367.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"736_CR24","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/ndt\/15.1.34","volume":"15","author":"J Syrjanen","year":"2000","unstructured":"Syrjanen J, Mustonen J, et al. Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy. Nephrol Dial Transplant. 2000;15(1):34\u201342.","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"736_CR25","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000045939","volume":"87","author":"I Ohno","year":"2001","unstructured":"Ohno I, Hosoya T, et al. Serum uric acid and renal prognosis in patients with IgA nephropathy. Nephron. 2001;87(4):333\u20139.","journal-title":"Nephron"},{"issue":"4","key":"736_CR26","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1046\/j.1523-1755.2001.0590041211.x","volume":"59","author":"LA Hebert","year":"2001","unstructured":"Hebert LA, Wilmer WA, et al. Renoprotection: one or many therapies? Kidney Int. 2001;59(4):1211\u201326.","journal-title":"Kidney Int"},{"issue":"6","key":"736_CR27","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1291\/hypres.24.691","volume":"24","author":"K Iseki","year":"2001","unstructured":"Iseki K, Oshiro S, et al. Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects. Hypertens Res. 2001;24(6):691\u20137.","journal-title":"Hypertens Res"},{"issue":"6","key":"736_CR28","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1172\/JCI40124","volume":"210","author":"H Kono","year":"2010","unstructured":"Kono H, Chen CJ, et al. Uric acid promotes an acute inflammatory response to sterile cell death in mice. J Clin Invest. 2010;210(6):1939\u201349.","journal-title":"J Clin Invest"},{"issue":"10","key":"736_CR29","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1172\/JCI57301","volume":"121","author":"N Asada","year":"2011","unstructured":"Asada N, Takase M, et al. Dysfunction of fibroblasts of extrarenal origin underlies renal fibrosis and renal anemia in mice. J Clin Invest. 2011;121(10):3981\u201390.","journal-title":"J Clin Invest"},{"issue":"1","key":"736_CR30","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2353\/ajpath.2010.090517","volume":"176","author":"BD Humphreys","year":"2010","unstructured":"Humphreys BD, Lin SL, et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol. 2010;176(1):85\u201397.","journal-title":"Am J Pathol"},{"key":"736_CR31","first-page":"80","volume":"14","author":"F Roch-Ramel","year":"1999","unstructured":"Roch-Ramel F, Guisan B. Renal transport of Urate in humans. News Physiol Sci. 1999;14:80\u20134.","journal-title":"News Physiol Sci"},{"issue":"2","key":"736_CR32","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/HJH.0b013e3282f240bf","volume":"26","author":"DB Corry","year":"2008","unstructured":"Corry DB, Eslami P, et al. Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J Hypertens. 2008;26(2):269\u201375.","journal-title":"J Hypertens"},{"issue":"17","key":"736_CR33","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra0800885","volume":"359","author":"DI Feig","year":"2008","unstructured":"Feig DI, Kang DH, et al. Uric acid and cardiovascular risk. N Engl J Med. 2008;359(17):1811\u201321.","journal-title":"N Engl J Med"},{"issue":"5","key":"736_CR34","doi-asserted-by":"crossref","first-page":"F471","DOI":"10.1152\/ajprenal.00560.2012","volume":"304","author":"ES Ryu","year":"2012","unstructured":"Ryu ES, Kim MJ, et al. Uric acid-induced phenotypic transition of renal tubular cells as a novel mechanism of chronic kidney disease. Am J Physiol Renal Physiol. 2012;304(5):F471\u201380.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"736_CR35","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1172\/JCI0215518","volume":"110","author":"M Iwano","year":"2002","unstructured":"Iwano M, Plieth D, et al. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest. 2002;110(3):341\u201350.","journal-title":"J Clin Invest"},{"issue":"6","key":"736_CR36","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.2353\/ajpath.2008.080433","volume":"173","author":"SL Lin","year":"2008","unstructured":"Lin SL, Kisseleva T, et al. Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am J Pathol. 2008;173(6):1617\u201327.","journal-title":"Am J Pathol"},{"issue":"2","key":"736_CR37","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00467-011-1772-6","volume":"27","author":"I Grgic","year":"2012","unstructured":"Grgic I, Duffield JS, et al. The origin of interstitial myofibroblasts in chronic kidney disease. Pediatr Nephrol. 2012;27(2):183\u201393.","journal-title":"Pediatr Nephrol"},{"issue":"11","key":"736_CR38","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/j.1745-7254.2008.00877.x","volume":"29","author":"H Chao","year":"2008","unstructured":"Chao H, Liu J, et al. Uric acid stimulates endothelin-1 gene expression associated with NADPH oxidase in human aortic smooth muscle cells. Acta Pharmacol Sin. 2008;29(11):1301\u201312.","journal-title":"Acta Pharmacol Sin"},{"issue":"6","key":"736_CR39","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1172\/JCI119297","volume":"99","author":"B Hocher","year":"1997","unstructured":"Hocher B, Thone-Reineke C, et al. Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension. J Clin Invest. 1997;99(6):1380\u20139.","journal-title":"J Clin Invest"},{"issue":"5","key":"736_CR40","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1681\/ASN.2013020195","volume":"25","author":"O Lenoir","year":"2014","unstructured":"Lenoir O, Milon M, et al. Direct action of endothelin-1 on podocytes promotes diabetic glomerulosclerosis. J Am Soc Nephrol. 2014;25(5):1050\u201362.","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"736_CR41","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1046\/j.1464-410x.2001.02173.x","volume":"87","author":"I Knerr","year":"2001","unstructured":"Knerr I, Nyul Z, et al. Increased endothelin-1 and decreased adrenomedullin gene expression in the stenotic tissue of congenital pelvi-ureteric junction obstruction in children. BJU Int. 2001;87(7):667\u201371.","journal-title":"BJU Int"},{"issue":"10","key":"736_CR42","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1097\/01.ASN.0000141313.84470.4B","volume":"15","author":"J Goddard","year":"2004","unstructured":"Goddard J, Eckhart C, et al. Endothelin a receptor antagonism and angiotensin-converting enzyme inhibition are synergistic via an endothelin B receptor-mediated and nitric oxide-dependent mechanism. J Am Soc Nephrol. 2004;15(10):2601\u201310.","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"736_CR43","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1161\/01.CIR.0000118499.69469.51","volume":"109","author":"J Goddard","year":"2004","unstructured":"Goddard J, Johnston NR, et al. Endothelin-a receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: a comparison of selective and combined endothelin receptor blockade. Circulation. 2004;109(9):1186\u201393.","journal-title":"Circulation"},{"issue":"2","key":"736_CR44","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.bbrc.2012.07.121","volume":"425","author":"N Arfian","year":"2012","unstructured":"Arfian N, Emoto N, et al. ET-1 deletion from endothelial cells protects the kidney during the extension phase of ischemia\/reperfusion injury. Biochem Biophys Res Commun. 2012;425(2):443\u20139.","journal-title":"Biochem Biophys Res Commun"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-017-0736-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T19:25:30Z","timestamp":1659727530000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-017-0736-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,31]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["736"],"URL":"https:\/\/doi.org\/10.1186\/s12882-017-0736-x","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,31]]},"article-number":"326"}}